ArticleBMC infectious diseases2025
Clinical analysis of the onset characteristics and inducing factors of atypical renal tuberculosis.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: A case of advanced renal tuberculosis with recurrent "kidney stones" and specific pathological manifestations.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the characteristics and inducing factors of atypical renal tuberculosis, and to improve the diagnosis of atypical renal tuberculosis. METHODS AND MATERIALS: We collected medical records and observed the pathological sections of renal tissue performed after nephrectomy from 217 patients diagnosed with renal tuberculosis using Mycobacterium tuberculosis culture, or/and Mycobacterium tuberculosis DNA (TB-DNA) testing using FQ-PCR(Fluorescent Quantitative Polymerase Chain Reaction), or/and postoperative pathology in the urology department of Hebei Chest Hospital from March 25, 2013 to February 6, 2024. Based on their onset characteristics, we divided them into the typical group (145 cases) and the atypical group (72 cases), and analyzed the chief symptoms and characteristics. Logistic regression was used to analyze the relevant factors, and the differences were compared in pathological changes of kidney, ureter, and bladder tissues after surgery, to explore the mechanism leading to atypical symptoms of renal tuberculosis.
results①In the typical group (66.82%), bladder irritation is the main clinical manifestation. In the atypical group (33.18%), there are no obvious symptoms of bladder irritation. The primary manifestations include localized pain, kidney discomfort, and secondary systemic or local disease signs.Additionally, the incidence rate among women in the atypical group is higher than in the typical group (p < 0.05).②Combined bladder tuberculosis is the only related factor of renal tuberculosis with severe urinary frequency, urgency, and dysuria as the main onset symptoms (p < 0.05). Only the LAM antibody and B lymphocyte counts were associated with the grouping of renal tuberculosis by logistic regression analysis (p < 0.05).③Bladder tuberculosis is more common in the typical group. At the same time, chronic inflammation is the main manifestation in the atypical group.
conclusions①Atypical renal tuberculosis is an important part of renal tuberculosis. Its onset of symptoms is insidious and atypical, without obvious bladder irritation symptoms, which should cause high vigilance and attention.②Uncomplicated bladder tuberculosis is the direct cause of the absence of bladder irritation symptoms in atypical renal tuberculosis, and reduced humoral immune function, and tubercular virulence may be the relevant factors inducing the onset of atypical symptoms in renal tuberculosis. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.